• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

C1抑制剂中的一个铰链区突变(丙氨酸436→苏氨酸)导致分子出现非底物样行为并发生聚合。

A hinge region mutation in C1-inhibitor (Ala436-->Thr) results in nonsubstrate-like behavior and in polymerization of the molecule.

作者信息

Aulak K S, Eldering E, Hack C E, Lubbers Y P, Harrison R A, Mast A, Cicardi M, Davis A E

机构信息

Division of Nephrology, Children's Hospital Research Foundation, University of Cincinnati College of Medicine, Ohio 45229-2899.

出版信息

J Biol Chem. 1993 Aug 25;268(24):18088-94.

PMID:8349686
Abstract

C1-inhibitor(Mo), a dysfunctional C1-inhibitor molecule produced in two kindred with type II hereditary angioedema, has a mutation at the P10 position (Ala436 to Thr). Like most serpins with hinge region mutations (P14, P12, P10), C1-inhibitor(Mo) loses its inhibitory activity. However, unlike the other hinge region mutations, this mutant is not converted to a substrate. As shown by nondenaturing gel electrophoresis, gel filtration, sucrose density gradient ultracentrifugation, and electron microscopy, C1-inhibitor(Mo) exists in both monomeric and multimeric forms. Polymerization probably results from reactive center loop insertion into the A sheet of an adjacent molecule. Native C1-inhibitor(Mo) was shown to have a thermal stability profile intermediate to those of intact and of cleaved normal C1-inhibitor. Native C1-inhibitor(Mo) did not bind to monoclonal antibody KII, which binds only to reactive center-cleaved normal C1-inhibitor. It did, however, react with monoclonal antibody KOK12, which recognizes complexed or cleaved C1-inhibitor but not intact normal C1-inhibitor. Native C1-inhibitor(Mo), therefore, exists in a conformation similar to the complexed form of normal C1-inhibitor.

摘要

C1抑制因子(Mo)是在两个患有II型遗传性血管性水肿的家族中产生的一种功能失调的C1抑制因子分子,它在P10位置(丙氨酸436突变为苏氨酸)发生了突变。与大多数具有铰链区突变(P14、P12、P10)的丝氨酸蛋白酶抑制剂一样,C1抑制因子(Mo)失去了其抑制活性。然而,与其他铰链区突变不同的是,这种突变体不会转化为底物。如非变性凝胶电泳、凝胶过滤、蔗糖密度梯度超速离心和电子显微镜所示,C1抑制因子(Mo)以单体和多聚体形式存在。聚合作用可能是由于反应中心环插入相邻分子的A片层所致。天然C1抑制因子(Mo)的热稳定性介于完整的和裂解的正常C1抑制因子之间。天然C1抑制因子(Mo)不与单克隆抗体KII结合,该抗体仅与反应中心裂解的正常C1抑制因子结合。然而,它确实与单克隆抗体KOK12发生反应,该抗体识别复合或裂解的C1抑制因子,但不识别完整的正常C1抑制因子。因此,天然C1抑制因子(Mo)以与正常C1抑制因子的复合形式相似的构象存在。

相似文献

1
A hinge region mutation in C1-inhibitor (Ala436-->Thr) results in nonsubstrate-like behavior and in polymerization of the molecule.C1抑制剂中的一个铰链区突变(丙氨酸436→苏氨酸)导致分子出现非底物样行为并发生聚合。
J Biol Chem. 1993 Aug 25;268(24):18088-94.
2
C1 inhibitor hinge region mutations produce dysfunction by different mechanisms.C1抑制剂铰链区突变通过不同机制导致功能障碍。
Nat Genet. 1992 Aug;1(5):354-8. doi: 10.1038/ng0892-354.
3
Substrate properties of C1 inhibitor Ma (alanine 434----glutamic acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor/substrate status.C1抑制剂Ma(丙氨酸434----谷氨酸)的底物特性。遗传和结构证据表明,P12区域包含丝氨酸蛋白酶抑制剂/底物状态的关键决定因素。
J Biol Chem. 1991 May 15;266(14):9216-21.
4
Characterization of C1 inhibitor-Ta. A dysfunctional C1INH with deletion of lysine 251.
J Biol Chem. 1996 Sep 27;271(39):24307-12. doi: 10.1074/jbc.271.39.24307.
5
Mutations in the C1 inhibitor gene that result in hereditary angioneurotic edema.C1抑制剂基因的突变会导致遗传性血管性水肿。
Behring Inst Mitt. 1993 Dec(93):313-20.
6
The functional integrity of the serpin domain of C1-inhibitor depends on the unique N-terminal domain, as revealed by a pathological mutant.一种病理性突变体表明,C1抑制剂丝氨酸蛋白酶抑制剂结构域的功能完整性取决于独特的N端结构域。
J Biol Chem. 2003 Aug 8;278(32):29463-70. doi: 10.1074/jbc.M302977200. Epub 2003 May 27.
7
COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinsertion and subsequent multimerization.丝氨酸蛋白酶抑制剂C1抑制剂中的羧基末端取代导致环过度插入并随后发生多聚化。
J Biol Chem. 1995 Feb 10;270(6):2579-87. doi: 10.1074/jbc.270.6.2579.
8
Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site.功能失调的C1抑制剂Ta:赖氨酸-251的缺失导致一个N-糖基化位点的获得。
Proc Natl Acad Sci U S A. 1990 Sep;87(17):6786-90. doi: 10.1073/pnas.87.17.6786.
9
Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein.无血管性水肿家族中的独特C1抑制因子功能障碍。II. Ala443→Val替代的鉴定及重组突变蛋白的功能分析。
J Clin Invest. 1995 Mar;95(3):1299-305. doi: 10.1172/JCI117780.
10
Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function.
J Clin Invest. 1995 Jan;95(1):350-9. doi: 10.1172/JCI117663.

引用本文的文献

1
Insights into the pathogenesis of hereditary angioedema using genetic sequencing and recombinant protein expression analyses.遗传性血管性水肿发病机制的遗传学测序和重组蛋白表达分析研究。
J Allergy Clin Immunol. 2023 Apr;151(4):1040-1049.e5. doi: 10.1016/j.jaci.2022.11.027. Epub 2022 Dec 29.
2
Strand 1A variant in neuroserpin shows increased aggregation and no loss of inhibition: implication in ameliorating polymerization to retain activity.神经丝氨酸蛋白酶抑制剂 1A 变异体显示出增加的聚集而没有抑制丧失:改善聚合以保留活性的意义。
Biosci Rep. 2022 Dec 22;42(12). doi: 10.1042/BSR20221825.
3
Variants and C1-INH Biological Function: A Close Relationship With C1-INH-HAE.
变体与C1-INH生物学功能:与C1-INH相关性血管性水肿的密切关系
Front Allergy. 2022 Mar 31;3:835503. doi: 10.3389/falgy.2022.835503. eCollection 2022.
4
Intermittent C1-Inhibitor Deficiency Associated with Recessive Inheritance: Functional and Structural Insight.间歇性 C1 抑制剂缺乏症与隐性遗传相关:功能和结构见解。
Sci Rep. 2018 Jan 17;8(1):977. doi: 10.1038/s41598-017-16667-w.
5
Genetics of Hereditary Angioedema Revisited.遗传性血管性水肿的遗传学再探讨。
Clin Rev Allergy Immunol. 2016 Oct;51(2):170-82. doi: 10.1007/s12016-016-8543-x.
6
Presence of C1-inhibitor polymers in a subset of patients suffering from hereditary angioedema.遗传性血管性水肿患者亚组中C1抑制剂聚合物的存在情况。
PLoS One. 2014 Nov 4;9(11):e112051. doi: 10.1371/journal.pone.0112051. eCollection 2014.
7
Hepatic fibrosis and carcinogenesis in α1-antitrypsin deficiency: a prototype for chronic tissue damage in gain-of-function disorders.α1-抗胰蛋白酶缺乏症中的肝纤维化和癌变:功能获得性疾病中慢性组织损伤的典型范例。
Cold Spring Harb Perspect Biol. 2011 Mar 1;3(3):a005801. doi: 10.1101/cshperspect.a005801.
8
Crystallographic and cellular characterisation of two mechanisms stabilising the native fold of alpha1-antitrypsin: implications for disease and drug design.稳定α1-抗胰蛋白酶天然折叠的两种机制的晶体学和细胞特征:对疾病和药物设计的启示
J Mol Biol. 2009 Apr 10;387(4):857-68. doi: 10.1016/j.jmb.2009.01.069. Epub 2009 Feb 14.
9
Small molecules block the polymerization of Z alpha1-antitrypsin and increase the clearance of intracellular aggregates.小分子可阻断Zα1-抗胰蛋白酶的聚合,并增加细胞内聚集体的清除率。
J Med Chem. 2007 Nov 1;50(22):5357-63. doi: 10.1021/jm070687z. Epub 2007 Oct 5.
10
Probing the local conformational change of alpha1-antitrypsin.探究α1-抗胰蛋白酶的局部构象变化。
Protein Sci. 2007 Sep;16(9):1842-50. doi: 10.1110/ps.072911607. Epub 2007 Jul 27.